Results revealed that UBE2L3 expression in NSCLC tissues was higher than that of non-tumor tissues, with a significant difference at the mRNA (Supplementary Figure 1A) and protein levels (Figure 1A and Figure 1B, p<0.01). The gene discussed is UBE2L3; the disease is neoplasm.